Sun Pharma launches Ezallor Sprinkle™ (rosuvastatin) capsules

Sun Pharma launches Ezallor Sprinkle™ (rosuvastatin) capsules

Jul 15, 2019 04:07 IST capital market

Sun Pharmaceutical Industries announced the U.S. launch of Ezallor Sprinkle™ (rosuvastatin) capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swallowing, a problem that is estimated to affect approximately 30- 35% of long-term care residents.

Ezallor Sprinkle is formulated as extended-release-coated pellets that may be sprinkled over soft food such as applesauce, can be swallowed whole, or administered via a nasogastric tube to facilitate long-term, once-daily administration. Ezallor Sprinkle joins Kapspargo Sprinkle™ (metoprolol succinate) extended-release capsules as the second product in the Sun Pharma portfolio designed for individuals in long-term care.

Powered by Capital Market - Live News

Related Story